RNTX- Rein Therapeutics, Inc.

Name: Rein Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Rein Therapeutics, Inc. (RNTX) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 36 sells. RNTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Voss Capital, LP	926.4K	$1.08M	-
Dir	Musso Alan A	17.5K	$20.5K	-
Dir	Ambros Reinhard J.	17.5K	$20.5K	-
Dir	Aivado Manuel	17.5K	$20.5K	-
Dir	Fairey William	17.5K	$20.5K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 14, 2025	Voss Capital, LP	10% Owner	Buy	104,183	$1.22	$127,592.92	+12.7%	-6.4%	-
Oct 28, 2025	Voss Capital, LP	10% Owner	Buy	306,050	$1.38	$423,465.64	+14.8%	+17.4%	-
Dec 5, 2024	Windsor James Brian45	President And CEO	Buy	400	$2.24	$897.61	New	-12.1%	-41.4%
Jun 17, 2024	University Of Texas/texas Am Investment Management Co87	10% Owner	Sell	6,607	$3.26	$21,567.75	-0.2%	-13.1%	-43.9%
Jun 12, 2024	University Of Texas/texas Am Investment Management Co87	10% Owner	Sell	24,671	$3.27	$80,709.83	-0.3%	-15.7%	-39.4%
Jun 7, 2024	University Of Texas/texas Am Investment Management Co87	10% Owner	Sell	12,315	$3.29	$40,528.30	-0.1%	-10.8%	-38.3%
May 1, 2024	University Of Texas/texas Am Investment Management Co87	10% Owner	Sell	31,151	$4.47	$139,102.92	-	-44.5%	-60.6%
Dec 15, 2023	Windsor James Brian45	President And COO	Buy	225	$3.37	$758.25	New	+45.5%	-40.5%
Nov 20, 2023	Windsor James Brian45	President And COO	Buy	5,076	$1.97	$9,987.03	+11,035%	+149.7%	+49.2%
Jan 8, 2021	Satter Muneer A58	See Remarks	Buy	9,000,000	$1.10	$9,900,000.00	+118.3%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC